Showing results (251-260 of 291) with videos related to

Sort By:
Pageof 30
Cancer Treatment Reports|November 1, 1979
Phase I trial of bruceantinM B Garnick, R H Blum, G P Canellos, et al.
Bioorganic & Medicinal Chemistry Letters|January 1, 1999
Hydroxamate-based inhibitors of low affinity IgE receptor (CD23) processingS Bailey, B Bolognese, D R Buckle, et al.
ESMO Open|March 12, 2024
Impact of KRAS<sup>G12</sup> mutations on survival with trifluridine/tipiracil plus bevacizumab in patients with refractory metastatic colorectal cancer: post hoc analysis of the phase III SUNLIGHT trialJ Tabernero, J Taieb, M Fakih, et al.
Bioorganic & Medicinal Chemistry Letters|January 1, 1999
Selective inhibition of low affinity IgE receptor (CD23) processingS Bailey, B Bolognese, D R Buckle, et al.
Analytical Biochemistry|October 21, 1999
Chemically synthesized ubiquitin extension proteins detect distinct catalytic capacities of deubiquitinating enzymesR Layfield, K Franklin, M Landon, et al.
Archives of Surgery (Chicago, Ill. : 1960)|June 1, 1991
A pilot study of sphincter-sparing management of adenocarcinoma of the rectumG Steele, P Busse, M S Huberman, et al.
Cancer|November 20, 1997
Quality of life for adult leukemia survivors treated on clinical trials of Cancer and Leukemia Group B during the period 1971-1988: predictors for later psychologic distressD B Greenberg, A B Kornblith, J E Herndon, et al.
Leukemia|May 1, 1991
Phase III trial of brief intensive treatment of adult acute lymphocytic leukemia comparing daunorubicin and mitoxantrone: a CALGB StudyJ Cuttner, R Mick, D R Budman, et al.
Journal of the National Cancer Institute|November 17, 1993
Preoperative and postoperative combination chemotherapy for potentially resectable gastric carcinomaJ A Ajani, R J Mayer, D M Ota, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 1, 1989
The modulation of fluorouracil with leucovorin in metastatic colorectal carcinoma: a prospective randomized phase III trial. Gastrointestinal Tumor Study GroupN Petrelli, H O Douglass, L Herrera, et al.
Pageof 30